• Assess the presence and severity or irritability in patients with mood disorder;
  • Describe the long-term consequences of elevated irritability;
  • Identify the link between irritability and suicide-related outcomes; and
  • Discuss the potential of ketamine as a pharmacological probe for developing novel therapeutics
Session date: 
10/06/2023 - 12:00pm CDT to 10/07/2023 - 11:59pm CDT
Location: 
JPS Health Network
1501 S. Main Street
Fort Worth, TX 76104
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 AOA Category 2-A
  • 1.00 HSC Participation

Please login or register to take this course.